Temasek-backed SeaTown invests $115m in AddVita

AddVita will use the funds to enact its ‘buy-and-build’ strategy.

Temasek-backed SeaTown Holdings International invested $115m in Singapore-headquartered healthcare and life sciences firm AddVita.

AddVita sells medical devices and diagnostic equipment to hospitals, clinics, and medical professionals. It is also a distributor of life sciences equipment, instruments, and consumables essential for medical and research labs.

According to SeaTown, the funds will be used by AddVita to acquire niche businesses in Asia that specialise in distributing high-quality medical, laboratory and pharmaceutical products and services.

“The healthcare distribution sector is resilient, with robust secular growth tailwinds,” said Dickson Loo, Managing Director of Private Equity at SeaTown.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia